本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Syndax Pharmaceuticals, Inc.

19.99
+0.01000.05%
成交量:64.22萬
成交額:1,296.50萬
市值:17.63億
市盈率:-7.16
高:20.55
開:19.96
低:19.85
收:19.98
52周最高:25.59
52周最低:8.59
股本:8,820.06萬
流通股本:7,469.08萬
量比:0.41
換手率:0.86%
股息:- -
股息率:- -
每股收益(TTM):-2.7913
每股收益(LYR):-3.2949
淨資產收益率:-189.53%
總資產收益率:-25.12%
市淨率:42.36
市盈率(LYR):-6.07

資料載入中...

2026/06/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/11

重要事件披露

Form 8-K - Current report
2026/06/11

重要事件披露

Form 8-K - Current report
2026/06/04

重要事件披露

Form 8-K - Current report
2026/06/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/30

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/02/26

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/12

重要事件披露

Form 8-K - Current report
2025/12/19

重要事件披露

Form 8-K - Current report